Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-alpha release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors.

about

Dual effect of cAMP agonist on ameliorative function of PKA inhibitor in morphine-dependent mice Amyloid beta peptide-(1-42) induces internalization and degradation of beta2 adrenergic receptors in prefrontal cortical neurons

P2860

Q28298439-98BEF6C4-C1D4-44E4-B6E2-DE3827661BD5 Q35213182-543FA410-E5C0-4D04-BDD2-080545B5F225

P2860

Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-alpha release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors.

Item

http://www.wikidata.org/entity/Q42130498

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Phosphodiesterase 4 inhibitors ...... ent protein kinase inhibitors.

@en

Phosphodiesterase 4 inhibitors ...... ent protein kinase inhibitors.

@nl

type

Item

label

Phosphodiesterase 4 inhibitors ...... ent protein kinase inhibitors.

@en

Phosphodiesterase 4 inhibitors ...... ent protein kinase inhibitors.

@nl

prefLabel

Phosphodiesterase 4 inhibitors ...... ent protein kinase inhibitors.

@en

Phosphodiesterase 4 inhibitors ...... ent protein kinase inhibitors.

@nl

P1476

Phosphodiesterase 4 inhibitors ...... ent protein kinase inhibitors.

@en

P2093

Berdyshev E

http://www.w3.org/2001/XMLSchema#string

Boichot E

http://www.w3.org/2001/XMLSchema#string

Coqueret O

http://www.w3.org/2001/XMLSchema#string

Germain N

http://www.w3.org/2001/XMLSchema#string

Hichami A

http://www.w3.org/2001/XMLSchema#string

Lagente V

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple cyclic nucleotide phosphodiesterases

Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromoc

cGMP-dependent protein kinase mediates the reduction of Ca2+ by cAMP in vascular smooth muscle cells.

The specific type IV phosphodiesterase inhibitor rolipram suppresses tumor necrosis factor-alpha production by human mononuclear cells.

Activation of protein kinase by physiological concentrations of cyclic AMP.

Cross-activation: overriding cAMP/cGMP selectivities of protein kinases in tissues.

Cyclic AMP-elevating agents prolong or inhibit eosinophil survival depending on prior exposure to GM-CSF

Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors.

The nitric oxide and cGMP signal transduction system: regulation and mechanism of action.

Inhibitors of cyclic nucleotide phosphodiesterase isoenzymes--their potential utility in the therapy of asthma.

P304

425-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/S0962935196000580

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1996-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5375308

http://www.w3.org/2001/XMLSchema#string

P698

18475747

http://www.w3.org/2001/XMLSchema#string

P932

2365824

http://www.w3.org/2001/XMLSchema#string

Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-alpha release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors.

about

P2860

P2860

Phosphodiesterase 4 inhibitors and db-cAMP inhibit TNF-alpha release from human mononuclear cells. Effects of cAMP and cGMP-dependent protein kinase inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932